Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1816 1
1824 1
1845 1
1857 2
1860 1
1861 1
1864 1
1874 1
1875 1
1897 1
1900 1
1901 1
1906 1
1907 1
1916 3
1917 1
1918 1
1919 5
1920 2
1921 6
1922 2
1923 1
1924 2
1925 2
1926 1
1927 4
1928 5
1930 2
1931 2
1932 3
1934 1
1935 3
1936 2
1937 1
1940 1
1944 1
1946 3
1947 3
1948 4
1950 3
1951 2
1952 1
1953 1
1954 3
1955 4
1957 1
1958 3
1959 1
1960 8
1961 1
1962 1
1963 9
1964 4
1965 4
1966 9
1967 16
1968 13
1969 14
1970 15
1971 11
1972 33
1973 23
1974 24
1975 191
1976 215
1977 205
1978 208
1979 250
1980 323
1981 327
1982 403
1983 457
1984 551
1985 612
1986 704
1987 840
1988 992
1989 1284
1990 1401
1991 1622
1992 1756
1993 2159
1994 2300
1995 2420
1996 2839
1997 2991
1998 3310
1999 3543
2000 3942
2001 4340
2002 4449
2003 5156
2004 5656
2005 8640
2006 10157
2007 11065
2008 11784
2009 12632
2010 13935
2011 15548
2012 17010
2013 18279
2014 19611
2015 20693
2016 19509
2017 19474
2018 22788
2019 24150
2020 27518
2021 30931
2022 30143
2023 27339
2024 23926
2025 362

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383,693 results

Results by year

Filters applied: . Clear all
Page 1
Clinical performance of one shade universal composite resin and nanohybrid composite resin as full coronal esthetic restorations in primary maxillary incisors: A randomized controlled trial.
Zulekha, Vinay C, Uloopi KS, RojaRamya KS, Penmatsa C, Ramesh MV. Zulekha, et al. J Indian Soc Pedod Prev Dent. 2022 Apr-Jun;40(2):159-164. doi: 10.4103/jisppd.jisppd_151_22. J Indian Soc Pedod Prev Dent. 2022. PMID: 35859408 Free article. Clinical Trial.
RESULTS: On comparison of Omnichroma and Tetric-N-Ceram groups, no statistically significant difference was observed in the color match at baseline (P = 0.716) as well as color stability (P = 0.575 at 6 months and 0.990 at 12 months) and retention (P = 0.153 …
RESULTS: On comparison of Omnichroma and Tetric-N-Ceram groups, no statistically significant difference was observed in the color mat …
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.
Kim ST, Kim SY, Lee J, Yun SH, Kim HC, Lee WY, Kim TW, Hong YS, Lim SB, Baek JY, Oh JH, Ahn JB, Shin SJ, Han SW, Kim SG, Kang SY, Sym SJ, Zang DY, Kim YH, Choi IS, Kang JH, Kim MJ, Park YS. Kim ST, et al. J Clin Oncol. 2022 Nov 20;40(33):3868-3877. doi: 10.1200/JCO.21.02962. Epub 2022 Jun 30. J Clin Oncol. 2022. PMID: 35772045 Free PMC article. Clinical Trial.
PATIENTS AND METHODS: This open-label, randomized, phase III, noninferiority trial randomly assigned patients with high-risk stage II and III CRC to 3 and 6 months of oxaliplatin with 6 months of fluoropyrimidine groups (3- and 6-month arms, respectively). .. …
PATIENTS AND METHODS: This open-label, randomized, phase III, noninferiority trial randomly assigned patients with high-risk stage II and II …
Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Panahi Y, et al. Skinmed. 2015 Jan-Feb;13(1):15-21. Skinmed. 2015. PMID: 25842469 Clinical Trial.
Patients with AGA were randomly assigned to rosemary oil (n = 50) or minoxidil 2% (n = 50) for a period of 6 months. After a baseline visit, patients returned to the clinic for efficacy and safety evaluations every 3 months. ...In contrast, both groups …
Patients with AGA were randomly assigned to rosemary oil (n = 50) or minoxidil 2% (n = 50) for a period of 6 months. Af …
Veganism and body weight: An N of 1 self-experiment.
Robinson E. Robinson E. Physiol Behav. 2023 Oct 15;270:114301. doi: 10.1016/j.physbeh.2023.114301. Epub 2023 Jul 18. Physiol Behav. 2023. PMID: 37474086 Free article.
In study phase 1, body weight change was -0.8 kg over 1 month of veganism (vs. +0.5 kg non-vegan month). In study phase 2, weight change was -1.2 kg over two veganism months (vs. +1.6 kg non-vegan months). ...Veganism appeared to reduce body weight in …
In study phase 1, body weight change was -0.8 kg over 1 month of veganism (vs. +0.5 kg non-vegan month). In study phase 2, wei …
Myopic shift after Salzmann nodule excision.
Witsberger EM, Maguire LJ, Patel SV. Witsberger EM, et al. J Cataract Refract Surg. 2021 Dec 1;47(12):1568-1572. doi: 10.1097/j.jcrs.0000000000000685. J Cataract Refract Surg. 2021. PMID: 34108404

Spherical equivalent manifest refractive error was -0.27 2.66 diopters (D) before nodule excision and became more myopic (-1.10 2.78 D) at 1 month after nodule excision (n = 69, P < .001) with no change at 12 months (n = 14, P = .13). ...Km increase

Spherical equivalent manifest refractive error was -0.27 2.66 diopters (D) before nodule excision and became more myopic (-1.10 2.78 D) at 1 …
Lifetime and Acute Stress Predict Functional Outcomes Following Stroke: Findings From the Longitudinal STRONG Study.
Holman EA, Cramer SC; STRONG Study Investigators. Holman EA, et al. Stroke. 2023 Nov;54(11):2794-2803. doi: 10.1161/STROKEAHA.123.043356. Epub 2023 Sep 28. Stroke. 2023. PMID: 37767737 Free PMC article.
Participants were interviewed 3 times: acute admission (acute stress; Acute Stress Disorder Interview), 3 months (Fugl-Meyer Upper Extremity motor impairment [Fugl-Meyer Upper Arm Assessment; N=431], modified Rankin Scale [3 months; N=542], Stroke Impa …
Participants were interviewed 3 times: acute admission (acute stress; Acute Stress Disorder Interview), 3 months (Fugl-Meyer Upper Ex …
Domain-specific cognitive impairment 6 months after stroke: The value of early cognitive screening.
Milosevich ET, Moore MJ, Pendlebury ST, Demeyere N. Milosevich ET, et al. Int J Stroke. 2024 Mar;19(3):331-341. doi: 10.1177/17474930231205787. Epub 2023 Oct 14. Int J Stroke. 2024. PMID: 37749759 Free PMC article.
METHODS: A prospective stroke cohort completed the Oxford Cognitive Screen acutely (2 weeks) and 6 months post-stroke. We determined the prevalence of acute and 6-month domain-specific impairment and proportion of change in performance from acute to 6 months. …
METHODS: A prospective stroke cohort completed the Oxford Cognitive Screen acutely (2 weeks) and 6 months post-stroke. We determined …
Tinnitus modulation by stapedectomy.
Chang CY, Cheung SW. Chang CY, et al. Otol Neurotol. 2014 Jul;35(6):1065-9. doi: 10.1097/MAO.0000000000000370. Otol Neurotol. 2014. PMID: 24751749
Demographic information, preoperative and postoperative audiometric data at 1 month, and TFI scores measured preoperatively within 1 month of stapedectomy and postoperatively at 1 and 6 months were captured and analyzed. RESULTS: Stapedectomy has its largest …
Demographic information, preoperative and postoperative audiometric data at 1 month, and TFI scores measured preoperatively within 1 …
The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease.
Huang L, Jiang Z, Zhou J, Chen Y, Huang H. Huang L, et al. Front Endocrinol (Lausanne). 2022 May 16;13:835880. doi: 10.3389/fendo.2022.835880. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35651979 Free PMC article.
METHODS: We conducted a retrospective study to observe the differences in thyroid function and TRAB trends between pre-vaccination (n=412) and post-vaccination (n=231) groups at an interval of 2 months. We then retrospectively observed the differences in seru …
METHODS: We conducted a retrospective study to observe the differences in thyroid function and TRAB trends between pre-vaccination (n
Management of Primary Hepatopancreatobiliary and Ampulla Large Cell Neuroendocrine Carcinoma.
Zhu J, Xiao W, Li Y. Zhu J, et al. J Laparoendosc Adv Surg Tech A. 2022 Jun;32(6):639-645. doi: 10.1089/lap.2021.0482. Epub 2021 Oct 11. J Laparoendosc Adv Surg Tech A. 2022. PMID: 34637632
Results: In the entire cohort, the median overall survival (OS) was 10 months. For nonmetastatic patients, the median OS was 32 months for surgery of the primary tumor alone (n = 17), 19 months for surgery of the primary tumor and adjuvant therapy ( …
Results: In the entire cohort, the median overall survival (OS) was 10 months. For nonmetastatic patients, the median OS was 32 mo
383,693 results
You have reached the last available page of results. Please see the User Guide for more information.